Brief: Theranexus End-Sept Available Funds At EUR 11.9 Mln
15/10/2020 17:10
Oct 15 (Reuters) - Theranexus SA ALTHX.PA :
* THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 SEPTEMBER 2020
* TOTAL AVAILABLE FUNDS ON 30 SEPTEMBER 2020 STAND AT EUR 11.9 M
* IS CURRENTLY IN ACTIVE DISCUSSIONS WITH POTENTIAL INDUSTRIAL PARTNERS TO CONTINUE CLINICAL
DEVELOPMENT OF THN102 FOR PARKINSON'S DISEASE
Source text for Eikon: ID:nACT65593
Further company coverage: ALTHX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease